Cynthia Li

Company: CytomX

Job title: Associate Director, Business Development

Seminars:

CytomX: PROBODY® Conditional Activation Technology Designed to Expand ADC Target Landscape 4:00 pm

Sharing industry-leading PROBODY® masking technology which leverages elevated protease activity in the tumor microenvironment and is designed to increase the therapeutic index by reducing on-target off-tumor toxicities while potentially maintaining potent anti-tumor efficacy Discussing PROBODY® platform with proof of mechanism: stability in circulation, intratumoral activation and single agent activity across multiple indications Outlining how PROBODY®…Read more

day: Day One - PM